ARCHIVES

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

This article is from The Cancer Letter archive.

Vol. 29 No. 40 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

February 1, 1991

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012